Charles & Colvard (CTHR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Duc Pham, a 9.6% shareholder, is soliciting proxies to elect himself to the Board, citing the need for significant leadership change to maximize shareholder value.
The proxy contest features three slates: Pham, five Company Nominees, and three RiverStyx Nominees, with shareholders able to vote for up to five candidates using a universal proxy card.
Pham's campaign is motivated by persistent revenue declines, GAAP losses, and poor stock performance, with a focus on operational turnaround and customer-centric product strategy.
Pham proposes immediate inventory clearance, a shift to certified lab-grown diamonds, and a design-led brand vision to restore growth and profitability.
Voting matters and shareholder proposals
Shareholders will vote to elect five directors, ratify the appointment of BDO USA, P.C. as auditor, approve executive compensation on an advisory basis, and determine the frequency of future say-on-pay votes.
Pham recommends voting for himself and withholding votes from Company Nominees, making no recommendation on management proposals.
Voting is via a BLUE universal proxy card, with detailed instructions for both record and beneficial owners.
Board of directors and corporate governance
The Board currently has five members, all up for election; Pham seeks to join to provide independent, industry-experienced oversight.
If elected, Pham would be a minority director unless joined by RiverStyx Nominees, potentially shifting Board control.
Pham advocates for a new President of Design & Product Excellence role to drive design strategy and accountability.
Latest events from Charles & Colvard
- Court-ordered annual meeting set for October 13, 2025, with limited agenda and board elections.CTHR
Proxy Filing1 Dec 2025 - Shareholders face a contested Board election and key governance votes amid ongoing financial challenges.CTHR
Proxy Filing1 Dec 2025 - Director nominations by a shareholder were invalidated; Board to recommend elections at the Annual Meeting.CTHR
Proxy Filing1 Dec 2025 - Proxy contest seeks to replace four directors to address financial and governance concerns.CTHR
Proxy Filing1 Dec 2025 - Riverstyx seeks board control with three nominees and challenges a dilutive stock issuance.CTHR
Proxy Filing1 Dec 2025 - Board recommends its director slate, annual say-on-pay, and cost-saving measures amid restructuring.CTHR
Proxy Filing1 Dec 2025 - FY2024 saw a 27% sales decline, $14.4M loss, and major liquidity risks for Charles & Colvard.CTHR
Q4 202430 Sep 2025